del Rosario, Maya C.
Walmsley, Sheyenne A.
Harrison, Barbara W.
Stephens, Crystal T.
Zettler, Bethany
Rivera-Cruz, Greysha
Agrawal, Priyal
Brower, Amy
Chigbu, Stephanie
Christensen, Kurt D.
Genetti, Casie A.
Givens, Richetta
Gold, Nina B.
Reeves, Inez V.
Schichter, Isabella
Shariat, Habib
Simon, Sandra
Smith, Hadley Stevens
Uveges, Melissa
Green, Robert C.
Holm, Ingrid A.
Pereira, Stacey
Funding for this research was provided by:
National Human Genome Research Institute (R00HG011491)
National Human Genome Research Institute (K08HG012811)
National Human Genome Research Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD114807)
National Center for Advancing Translational Sciences/NIH and the PrecisionLink Project at Boston Children’s Hospital (U01TR002623)
National Center for Advancing Translational Sciences and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01TR003201)
Article History
Received: 7 July 2025
Accepted: 5 January 2026
First Online: 28 January 2026
Declarations
:
: The study was approved by the Institutional Review Boards (IRBs) at Boston Children’s Hospital and Howard University in accordance with the United States Common Rule (45 CFR Part 46) and the Declaration of Helsinki. All participants provided informed consent.
: All authors consent to publication.
: NBG has received honoraria from Amby Genetics. HSS has received consulting income from Illumina. RCG receives compensation for advising the following companies: Allelica, Atria, Fabric, Genomic Life and Juniper Genomics; and is co-founder of Genome Medical and Nurture Genomics. The remaining authors declare no conflicts.